Roche aims to ‘underwhelm’ on SMA drug price to challenge rivals Press Trust of India Jan 14, 2020 Spinraza's list price is $750,000 in the first year, and $375,000 thereafter, while Novartis's gene therapy for the genetic muscle…
Proposed cap on trade margins will not hurt pharma cos Press Trust of India Dec 4, 2019 Citing media reports Fitch said, the National Pharmaceutical Pricing Authority is making progress in reaching a consensus with…
